Theralase Technologies Inc.
TLTFF
$0.17
$0.014.06%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.66M | -2.94M | -3.10M | -3.06M | -3.20M |
| Total Depreciation and Amortization | 187.40K | 190.20K | 187.00K | 189.00K | 193.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 358.70K | 409.40K | 483.00K | 446.60K | 398.60K |
| Change in Net Operating Assets | -184.30K | -24.60K | 605.90K | 86.40K | 713.20K |
| Cash from Operations | -2.29M | -2.36M | -1.83M | -2.33M | -1.89M |
| Capital Expenditure | 10.50K | -33.90K | -69.00K | -64.30K | -56.80K |
| Sale of Property, Plant, and Equipment | 1.40K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 11.90K | -33.90K | -69.00K | -64.30K | -56.80K |
| Total Debt Issued | 375.00K | 375.00K | 100.00K | -- | -- |
| Total Debt Repaid | -97.50K | -95.30K | -106.80K | -101.00K | -94.70K |
| Issuance of Common Stock | 3.76M | 2.98M | 2.40M | 3.04M | 2.81M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.00K | -2.00K | -4.00K | -2.00K | -2.00K |
| Cash from Financing | 2.91M | 2.34M | 1.72M | 2.13M | 1.97M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 626.90K | -59.00K | -175.50K | -273.20K | 18.00K |